5d
Pharmaceutical Technology on MSNInsilico raises $110m to develop drug pipeline and AI platformInsilico Medicine has completed a Series E round, raising $110m to progress the development of its pipeline of drugs and AI ...
Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...
The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...
Vancouver-based Absci to send first drug to clinical trials in what CEO calls a ‘huge milestone’
The company also announced a collaboration with chipmaker AMD to power its advanced de novo AI antibody design models, as well as AI biotechnology company Owkin to co-develop therapeutic candidates ...
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Insilico Medicine('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a $110 million Series E ...
Unveiled updates across proprietary pipeline and demonstrated new breakthroughs by AI platform at 2024 R&D Day Entered into collaboration with AMD, including $20 million strategic investment in Absci ...
Insilico, which earns revenue from licensing assets in its pipeline to clients ... further develop its AI platform, and advance the clinical validation of its flagship drug candidate for ...
We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results